Greenberg Traurig Expands MedTech Practice with Addition of Christopher Bolten

Press Releases

May 29, 2024

Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences & Medical Technology Practice.

SAN DIEGO, May 29, 2024 /PRNewswire-PRWeb/ — Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences & Medical Technology Practice. He will be based in the firm’s San Diego office.

Trained as a mechanical engineer, Bolten’s practice focuses on medical technology (MedTech). He helps medical device and digital health companies across the United States, Europe, and Israel build patent portfolios to protect and enforce their intellectual property (IP). Bolten also provides IP due diligence services for venture capital firms and advises on associated risks related to their MedTech investments.

“Health care companies are now thinking more like technology companies, so Chris’s area of practice is an essential addition to our robust IP and Patents and Innovation Strategies practices,” said G. Michelle Ferreira, senior vice president of the firm and co-managing shareholder of the San Francisco and Silicon Valley offices. “He has a broad cross-border practice that runs the gamut from startups seeking FDA approval for single devices to well-established multinational public companies; in other words, Chris’s clients could benefit from Greenberg Traurig’s vast global platform.”

Bolten has been advising digital health companies using artificial intelligence and machine learning before “AI” became household terminology. Whether it was working with companies that used AI to assist surgical robots or to analyze heart signals to help diagnose cardiac abnormalities like atrial fibrillation – a feature now found in FDA-approved consumer smartwatches – Bolten has been at the forefront of AI’s overlap with digital health for many years, where the goal has always been to enhance patient care.

“I worked with Chris when he was a junior attorney, and it’s been a joy to see his rise here in Southern California, where he is well-known in the tech and legal spaces,” Shareholder David A. Gay, Ph.D. said. “Chris will perfectly complement the existing life sciences practice we have developed both in San Diego and across the firm.”

Bolten’s previous work with wireless communication and cellular technology has come full circle; he has seen his own practice areas of communications and medical devices converge. More digital health companies are creating software and collecting data with the goal of helping patients receive targeted diagnoses or medical treatment, often with the help of AI.

“Greenberg Traurig’s footprint and global platform overlap neatly with where my clients are based,” Bolten said. “The firm has a stellar reputation in the IP and patent prosecution community, and I could not be more excited to join a first-class group of attorneys.”

Bolten received his J.D. from the Arizona State University Sandra Day O’Connor College of Law, magna cum laude, and a B.S. in mechanical engineering, with honors, from Michigan State University. He is admitted to practice law in California and before the U.S. Patent and Trademark Office, as well as the Federal Circuit Court of Appeals and District Courts in California, Colorado, and Texas. Bolten joins the firm from Eversheds Sutherland.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2750 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: http://www.gtlaw.com.

Media Contact

Joey Kaiser, Greenberg Traurig, 2128016983, Joey.Kaiser@gtlaw.com, https://www.gtlaw.com/en

Twitter

Cision View original content:https://www.prweb.com/releases/greenberg-traurig-expands-medtech-practice-with-addition-of-christopher-bolten-302155319.html

SOURCE Greenberg Traurig

YOU MAY ALSO LIKE

Yunji to Report Third Quarter 2024 Financial…

Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences &…

read more

Alithya reports Q2 results and adjusted EBITDA…

Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences &…

read more

90% of Industry Professionals Call for Greater…

Prominent Intellectual Property & Technology attorney Christopher C. Bolten has joined global law firm Greenberg Traurig, LLP as a shareholder in the Life Sciences &…

read more